344 related articles for article (PubMed ID: 24054931)
1. Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes.
Corona G; Rastrelli G; Maggi M
Best Pract Res Clin Endocrinol Metab; 2013 Aug; 27(4):557-79. PubMed ID: 24054931
[TBL] [Abstract][Full Text] [Related]
2. EMAS position statement: Testosterone replacement therapy in the aging male.
Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
[TBL] [Abstract][Full Text] [Related]
3. Risks and benefits of late onset hypogonadism treatment: an expert opinion.
Corona G; Vignozzi L; Sforza A; Maggi M
World J Mens Health; 2013 Aug; 31(2):103-25. PubMed ID: 24044106
[TBL] [Abstract][Full Text] [Related]
4. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE).
Isidori AM; Aversa A; Calogero A; Ferlin A; Francavilla S; Lanfranco F; Pivonello R; Rochira V; Corona G; Maggi M
J Endocrinol Invest; 2022 Dec; 45(12):2385-2403. PubMed ID: 36018454
[TBL] [Abstract][Full Text] [Related]
5. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
Magnussen LV
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
[TBL] [Abstract][Full Text] [Related]
6. Testosterone Replacement Therapy and Components of the Metabolic Syndrome.
Anaissie J; Roberts NH; Wang P; Yafi FA
Sex Med Rev; 2017 Apr; 5(2):200-210. PubMed ID: 28202344
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
Hackett G
Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
[TBL] [Abstract][Full Text] [Related]
8. Testosterone and metabolic syndrome: a meta-analysis study.
Corona G; Monami M; Rastrelli G; Aversa A; Tishova Y; Saad F; Lenzi A; Forti G; Mannucci E; Maggi M
J Sex Med; 2011 Jan; 8(1):272-83. PubMed ID: 20807333
[TBL] [Abstract][Full Text] [Related]
9. The complex association between metabolic syndrome and male hypogonadism.
Dimopoulou C; Goulis DG; Corona G; Maggi M
Metabolism; 2018 Sep; 86():61-68. PubMed ID: 29656047
[TBL] [Abstract][Full Text] [Related]
10. The Role of testosterone treatment in patients with metabolic disorders.
Corona G; Rastrelli G; Vignozzi L; Barbonetti A; Sforza A; Mannucci E; Maggi M
Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1091-1103. PubMed ID: 34085587
[TBL] [Abstract][Full Text] [Related]
11. MYTHS AND CONTROVERSIES IN HYPOGONADISM TREATMENT OF AGING MALES.
Ungureanu MC; Costache II; Preda C; Mogoş V; Vulpoi C; Leuştean L
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):325-33. PubMed ID: 26204632
[TBL] [Abstract][Full Text] [Related]
12. Late-onset hypogonadism and lifestyle-related metabolic disorders.
Braga PC; Pereira SC; Ribeiro JC; Sousa M; Monteiro MP; Oliveira PF; Alves MG
Andrology; 2020 Nov; 8(6):1530-1538. PubMed ID: 31991053
[TBL] [Abstract][Full Text] [Related]
13. Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment.
Huhtaniemi I
Asian J Androl; 2014; 16(2):192-202. PubMed ID: 24407185
[TBL] [Abstract][Full Text] [Related]
14. MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
Lapauw B; Kaufman JM
Eur J Endocrinol; 2020 Dec; 183(6):R167-R183. PubMed ID: 33105105
[TBL] [Abstract][Full Text] [Related]
15. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
[TBL] [Abstract][Full Text] [Related]
16. Patients with testosterone deficiency syndrome and type 2 diabetes.
Corona G; Maggi M
Arch Esp Urol; 2013 Sep; 66(7):711-22. PubMed ID: 24047631
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of testosterone replacement therapy for treating metabolic disturbances in late-onset hypogonadism: a systematic review and meta-analysis.
Kim SH; Park JJ; Kim KH; Yang HJ; Kim DS; Lee CH; Jeon YS; Shim SR; Kim JH
Int Urol Nephrol; 2021 Sep; 53(9):1733-1746. PubMed ID: 34089171
[TBL] [Abstract][Full Text] [Related]
18. Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.
Ko YH; Kim JJ
Asian J Androl; 2011 Jul; 13(4):563-8. PubMed ID: 21572448
[TBL] [Abstract][Full Text] [Related]
19. Is testosterone replacement therapy in males with hypogonadism cost-effective? An analysis in Sweden.
Arver S; Luong B; Fraschke A; Ghatnekar O; Stanisic S; Gultyev D; Müller E
J Sex Med; 2014 Jan; 11(1):262-72. PubMed ID: 23937088
[TBL] [Abstract][Full Text] [Related]
20. Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid profile, Diabetes Mellitus control), blood indices, liver enzymes, and prostate health indicators in elderly hypogonadal men.
Canguven O; Talib RA; El Ansari W; Yassin DJ; Salman M; Al-Ansari A
Andrologia; 2017 Dec; 49(10):. PubMed ID: 28295504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]